Malaysian healthcare firm Alps World Holding Berhad plans to go public by a merger with SPAC Globalink Funding (NASDAQ:GLLI) that pegs the enterprise worth of the corporate at $1.6B.
Shares of the mixed firm, which will probably be known as Alps Life Science, are anticipated to be listed on Nasdaq. The transaction is anticipated to shut in Q2, topic to shareholder approval.
Underneath the deal, Alps shareholders might obtain as much as 48M further shares by an earn-out provision if the mixed firm achieves sure milestones. All Alps shareholders will roll 100% of their holdings into the mixed firm, in accordance with a press release.